FBXW7 suppresses tumor development and progression in ovarian cancer by degrading YTHDF2 and enhancing the stability of the pro-apoptotic gene Bcl-2-modifying factor [37]. The gene discussed is YTHDF2; the disease is ovarian carcinoma.